Jobs / United States / Astrazeneca Pharmaceuticals Lp
Associate Director, Cell Therapy Trade Compliance Operations
Astrazeneca Pharmaceuticals Lp · 🇺🇸 US - Gaithersburg - MD
Sponsorship verdict
Sponsorship possible
One solid signal, not two — worth applying, and worth asking about sponsorship early.
- Employer is on a government sponsor recordThe US Department of Labor certified 99 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 31 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
- The posting doesn’t mention sponsorshipSilence isn’t a refusal — ask the recruiter before investing much time.
- No salary bar for this routeH-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area. Cap-subject employers enter a lottery weighted by wage level. Source: https://www.federalregister.gov/documents/2025/12/29/2025-23853/weighted-selection-process-for-registrants-and-petitioners-seeking-to-file-cap-subject-h-1b, rules effective 2026-02-27.
- What Astrazeneca Pharmaceuticals Lp paid sponsored hires in similar roles15 certified filings for “Associate Director Oncology Outcomes Research” (Medical Scientists, Except Epidemiologists) in MD: $126k–$185k, median $140k. Most were filed at wage level II (47%) — 2 lottery entries, ≈31% projected selection odds for cap-subject employers. Source: US Department of Labor LCA disclosure data (Oct 2025 – Jun 2026).
- Confirmed live todayWhen a source last listed this job as open.
US H-1B: cap-subject employers enter a lottery weighted by wage level — Level I gets 1 entry, Level IV gets 4 (DHS projected selection odds ≈15% at Level I to ≈61% at Level IV). Universities and non-profit research employers are cap-exempt. The $100,000 fee for new petitions from abroad is currently blocked by a court order (appeal pending).
A verdict summarises public evidence; it is not legal advice and never a guarantee — the employer and the immigration authority decide. Sign in to factor in where you can already work.
Or apply yourself on the official page →
Sponsor Radar — Astrazeneca Pharmaceuticals Lp
The US Department of Labor certified 99 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 31 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
Past sponsorship or register membership never guarantees sponsorship for this vacancy or for you. Full Sponsor Radar for Astrazeneca Pharmaceuticals Lp →
About the role
Associate Director, Cell Therapy Trade Compliance Operations Introduction to role: At AstraZeneca Cell Therapy, we are building the capabilities required to deliver complex, personalized therapies through a highly coordinated, patient-centered, and globally scalable supply chain. As our network, geographic footprint, and operational complexity continue to expand, trade compliance operations are increasingly critical to ensuring that patient materials, critical manufacturing inputs, intermediates, and finished product can move compliantly, predictably, and without avoidable delay across borders. The Associate Director, Cell Therapy Trade Compliance Operations leads the operating model for import/export and Free Trade Zone (FTZ) execution across the cell therapy network. This role is responsible for building scalable, reliable, and compliant operational processes; leading first-line escalation and business continuity for cross-border execution; and strengthening broker performance, visibility, digitization, and standardization to support future growth and commercial readiness. This role also provides people leadership for team members responsible for operational trade compliance execution and partners closely within Patient Supply Operations, Global Supply Chain, Quality, Regulatory, and Digital teams to ensure cross-border trade requirements strengthen the delivery system that supports patient and product journeys. This role is a hybrid position with a requirement to work in the office three days a week. Accountabilities: • Lead the trade compliance operating model for import/export and FTZ execution across the cell therapy network, including global execution rhythms, governance routines, escalation pathways, role clarity, and cross-site ways of working that support reliable daily operations. • Lead import/export and FTZ execution for patient materials, manufacturing inputs, intermediates, and finished product, ensuring compliant and timely execution of customs entry, shipment coordination, broker engagement, FTZ activity, and issue resolution in line with customs requirements, FDA/CBER import expectations, and internal procedures. • Own first-line escalation and continuity management for cross-border trade execution issues, including shipment holds, documentation issues, customs delays, broker performance concerns, and FTZ operational issues that may impact patient timelines, manufacturing continuity, or inventory control. • Drive process excellence and scalability across trade compliance operations through workflow simplification, bottleneck removal, standard work, and repeatable operating methods that support network expansion, increasing shipment volumes, and growing operational complexity. • Strengthen digital enablement and operational visibility by partnering with business and digital stakeholders to improve workflows, dashboards, KPI reporting, exception tracking, and data quality, reducing manual effort and enabling more scalable and data-driven trade compliance operations. • Own operational documentation and standard work for shipment execution, FTZ processes, broker coordination, escalation management, issue resolution, business continuity, and execution controls, ensuring SOPs, work instructions, playbooks, and training materials remain current, practical, and aligned to regulatory and business requirements. • Lead performance management and broker management for customs brokers, freight forwarders, and related service providers, including performance monitoring, service issue management, escalation handling, and operational input to scorecards and structured performance reviews. • Support network readiness and expansion for new countries, sites, lanes, produc